Andreas Syllaba, DO
Neuromusculoskeletal Medicine & OMM · Loveland, OHNPI 1063500932
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations.
Across 217 payments — averaging $19.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$787
- Medtronic$574
- AbbVie$562
- Boston Scientific$470
- Pfizer$197
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$150
- plus $1K from 31 others
What the payments were for
- Food & beverage$4,190100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 62 | $787 |
| Medtronic(2 entities) | 11 | $574 |
| AbbVie | 24 | $562 |
| Boston Scientific | 25 | $470 |
| Pfizer | 12 | $197 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $150 |
| Teva Pharmaceuticals USA, Inc. | 9 | $124 |
| GRT US Holding, Inc. | 6 | $124 |
| Abbott | 4 | $100 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $96 |
| Averitas Pharma Inc. | 4 | $86 |
| Nevro Corp. | 1 | $86 |
| Jazz Pharmaceuticals Inc. | 1 | $69 |
| Vertex | 3 | $67 |
| Vertos Medical, Inc. | 5 | $64 |
| Tersera Therapeutics LLC | 3 | $56 |
| IBSA Pharma Inc. | 4 | $55 |
| Nalu Medical, Inc. | 1 | $49 |
| Amgen | 3 | $49 |
| Scilex Pharmaceuticals Inc. | 3 | $45 |
| Merz Pharmaceuticals, LLC | 2 | $43 |
| Stimwave Technologies Incorporated | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Amneal Pharmaceuticals LLC | 2 | $28 |
| MDD US Operations, LLC | 1 | $27 |
| Lundbeck LLC | 1 | $25 |
| Globus Medical | 1 | $24 |
| Biodelivery Sciences International, Inc. | 2 | $24 |
| Painteq LLC | 1 | $24 |
| Saluda Medical Americas, Inc. | 1 | $16 |
| Tonix Medicines, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Curonix LLC | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Bioventus LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RESTORE$140
- INTELLIS ADAPTIVESTIM$120
- UBRELVY$119
- KYPHON Balloon Kyphoplasty$102
How this compares
Too few neuromusculoskeletal medicine & omm providers in Ohioto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 120 | $40,477 |
| BelbucaBuprenorphine Hcl | 37 | $31,768 |
| Xtampza ErOxycodone Myristate | 43 | $31,266 |
| NucyntaTapentadol Hcl | 20 | $20,604 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 739 | $20,350 |
| Nucynta ErTapentadol Hcl | 17 | $20,046 |
| OxycontinOxycodone Hcl | 18 | $10,852 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 516 | $8,518 |
| Lidocaine | 23 | $6,035 |
| Fentanyl | 62 | $6,022 |
| Pregabalin | 160 | $4,052 |
| Morphine Sulfate ErMorphine Sulfate | 159 | $3,469 |
| Gabapentin | 314 | $2,708 |
| Naloxone Hcl | 39 | $2,173 |
| Tizanidine Hcl | 136 | $938 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta, Nucynta Er | $787 | $103,685117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few neuromusculoskeletal medicine & omm providers in Ohioon file to place this against a meaningful peer group, so we don't.
Other neuromusculoskeletal medicine & omm in Loveland
- Carolyn GoldschmidtCleveland$80K
- John SawvelBeavercreek$1K
- Zachary WestTiffin$1K
- Zhan Tao YangWarrensville Heights$858
- Xavier DisabatoLima$614
- Ann HabenichtBeavercreek$560
- Judith OconnellBeavercreek$539
- Kevin ReidDayton$164
- Korrie Beverley-WatersWarrensville Heights$125
- Anna WrightAthens$73
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.